Recently, these data have been confirmed by analyzing through several molecular methods the lower airways of stable COPD patients with different grades of severity, showing increased expression of LC3A + LC3B in both smokers with normal lung function and in COPD patients compared to non-smoker subjects, suggesting thus an enhanced autophagic flux [17]. Here, MAP1LC3A is linked to chronic obstructive pulmonary disease.